36067 - Drugs (Answered)

Frank Field
To ask the Secretary of State for Health, if his Department will reconsider the Medicines and Healthcare Products Regulatory Authority exemption which prior to 2013 enabled organisations to send surplus medicines to (a) developing countries and (b) other countries outside of the EEA.

George Freeman

36037 - Warfarin: Clinics (Answered)

Mrs Cheryl Gillan
To ask the Secretary of State for Health, what assessment he has made of the potential merits of reclassifying warfarin clinics as anti-coagulation clinics in order to increase availability for anti-coagulation medicines other than warfarin which have been approved and recommended by NICE.

George Freeman

No assessment has been made of the merits of reclassification of warfarin clinics as anti-coagulation clinics as provision of these is a matter for clinical commissioning groups.

36035 - Atrial Fibrillation (Answered)

Mrs Cheryl Gillan
To ask the Secretary of State for Health, what assessment he has made of the reasons for the level of variation in (a) the amount of novel oral anti-coagulants and (b) other aspects of implementing NICE guidance on preventing strokes in patients with atrial fibrillation.

George Freeman

Guidance published by the National Institute for Health and Care Excellence (NICE) in June 2014 makes it clear that the choice of anticoagulant should be determined through discussion with the patient.

36034 - Anticoagulants (Answered)

Mrs Cheryl Gillan
To ask the Secretary of State for Health, what assessment his Department has made of the practical barriers to prescribing novel oral anti-coagulants at a local level; and what steps his Department is taking to enable patients to receive the most effective medicines to prevent strokes recommended by NICE.

George Freeman

Guidance published by the National Institute for Health and Care Excellence (NICE) in June 2014 makes it clear that the choice of anticoagulant should be determined through discussion with the patient.

36033 - Anticoagulants (Answered)

Mrs Cheryl Gillan
To ask the Secretary of State for Health, if he will take steps to ensure that there are not incentives to use particular brands of anticoagulants across the NHS; and if he will make a statement.

George Freeman

Guidance published by the National Institute for Health and Care Excellence (NICE) in June 2014 makes it clear that the choice of anticoagulant should be determined through discussion with the patient.

35762 - Progressive Supranuclear Palsy (Answered)

Kate Green
To ask the Secretary of State for Health, what funds the Government has allocated for research into progressive supranuclear palsy in each of the last three years; and what plans the Government has to allocate further funding for research to support early diagnosis of and effective treatments for that condition.

George Freeman

35511 - NHS: Vacancies (Answered)

Paula Sherriff
To ask the Secretary of State for Health, with reference to the advertisement on the Hays recruitment website by NHS England for a temporary Senior Deputy Head of Media Planning and Strategy on a daily rate of pay, whether the successful candidate for that post will be paid through (a) the NHS England payroll, (b) that agency or (c) a limited company.

George Freeman

35414 - Multiple Sclerosis: Drugs (Answered)

Simon Hoare
To ask the Secretary of State for Health, pursuant to the Answer of 22 February 2016 to Question 26606, whether it is his Department's intention that all patients diagnosed with multiple sclerosis will have access to the drugs previously covered by the Risk Sharing Scheme (a) until and (b) beyond the conclusion of the NICE Multiple Sclerosis MTA in 2017.

George Freeman

35068 - Cancer: Drugs (Answered)

Andrew Gwynne
To ask the Secretary of State for Health, what estimate he has made of the potential (a) number and (b) cost of drugs that might gain conditional approval under the new Cancer Drugs Fund.

George Freeman

Neither the Department nor NHS England has made any such assessment as it would be inappropriate to pre-empt the final recommendations of the National Institute for Health and Care Excellence.

35164 - Mesothelioma: Research (Answered)

Steve Rotheram
To ask the Secretary of State for Health, what steps his Department has taken to support research into mesothelioma.

George Freeman

The Government agrees that more mesothelioma research is needed and has taken measures to stimulate an increase in the level of research activity.

Pages